Regenicin, Inc. (RGIN) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Little Falls, NJ, 美国. 现任CEO为 Randall E. McCoy.
RGIN 拥有 IPO日期为 2009-11-16, 3 名全职员工, 在 Other OTC, 市值为 $15.35K.
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. The company's product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. Its products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.
